Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ

Journal of Infectious Diseases

Volumn 184, Issue 8, 2001, Pages 992-997

  Leoung, G S ^a   Stanford, J F ^a   Giordano, M F ^a   Stein, A ^a   Torres, R A ^a   Giffen, C A ^a   Wesley, M ^a   Sarracco, T ^a   Cooper, E C ^a   Dratter, V ^a   Smith, J J ^a   Frost, K R ^a  

^a Amer Foundation for AIDS Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; PLACEBO;

ADULT; ARTICLE; ASTHENIA; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FEVER; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; VIRUS REACTIVATION;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CONTINENTAL POPULATION GROUPS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PNEUMONIA, PNEUMOCYSTIS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0035888017     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/323353     Document Type: Article

References (36)

1. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS
2. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia in AIDS. San Francisco Community Prophylaxis Trial
3. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus
4. US Public Health Service/Infectious Diseases Society of America guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: A summary
5. Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease
6. Successful prophylaxis of Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole in AIDS patients with previous allergic reactions
7. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome
8. Primary prophylaxis for Pneumocystis carinii pneumonia: A randomized trial comparing co-trimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine
9. Clindamycin/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: A randomized, double-blind pilot trial
10. Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immanodeficiency virus disease: Results of a randomized trial
11. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis
12. Low-dose intermittent trimethoprim-sulfamethoxazole for prevention of Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection
13. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome
14. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone
15. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection
16. Efficacy and safety of rechallenge with low-dose trimethoprim-sulfamethoxazole in previously hypersensitive HIV-infected patients
17. Trimethoprim-sulfamethoxazole anaphylactoid reactions in patients with AIDS: Case reports and literature review
18. A severe, unusual reaction to trimethoprim-sulfamethoxazole in patients infected with human immunodeficiency virus
19. + lymphocyte count
20. A severe hypersensitive reaction to trimethoprim-sulfamethoxazole in a patient infected with human immunodeficiency virus
21. A severe systemic reaction to trimethoprim-sulfamethoxazole in a patient with human immunodeficiency virus
22. Pneumocystis carinii pneumonia: A comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies
23. Trimethoprim-sulfamethoxazole (TMP-SMX) desensitization in HIV patients with previously documented TMP-SMX intolerance
24. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: A prospective, noncrossover study
25. Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneamocystis carinii pneumonia
26. A randomized trial of daily and thrice-weekly trimethoprim/sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency-infected persons
27. Trimethoprim-sulfamethoxazole desensitization in the acquired immunodeficiency syndrome
28. Desensitization to trimethoprim sulfamethoxazole in patients with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia
29. Desensitization to sulfonamides in patients with HIV infection
30. Trimethoprim/sulfamethoxazole hypersensitivity and desensitization in HIV disease
31. Oral desensitization to sulfonamides in AIDS patients
32. Successful oral desensitization to TMP-SMZ in persons with HIV infection and prior hypersensitive reactions
33. Efficacy and safety of desensitization to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients
34. Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): Use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ
35. Efficacy and toxicity of two doses of trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus